David P. Snow

2019

In 2019, David P. Snow earned a total compensation of $1.9M as Chief Business Officer at Sevion Therapeutics, a 54% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$78,000
Option Awards$1,080,700
Salary$388,750
Stock Awards$288,250
Other$48,505
Total$1,884,205

Snow received $1.1M in option awards, accounting for 57% of the total pay in 2019.

Snow also received $78K in non-equity incentive plan, $388.8K in salary, $288.3K in stock awards and $48.5K in other compensation.

Rankings

In 2019, David P. Snow's compensation ranked 6,231st out of 13,971 executives tracked by ExecPay. In other words, Snow earned more than 55.4% of executives.

ClassificationRankingPercentile
All
6,231
out of 13,971
55th
Division
Manufacturing
2,339
out of 5,701
59th
Major group
Chemicals And Allied Products
853
out of 2,200
61st
Industry group
Drugs
720
out of 1,886
62nd
Industry
Biological Products, Except Diagnostic Substances
168
out of 389
57th
Source: SEC filing on April 1, 2020.

Snow's colleagues

We found three more compensation records of executives who worked with David P. Snow at Sevion Therapeutics in 2019.

2019

Gregory Williams

Sevion Therapeutics

Chief Operating Officer

2019

Robert Ward

Sevion Therapeutics

Chief Executive Officer

2019

Gregory Weaver

Sevion Therapeutics

Chief Financial Officer

News

In-depth

You may also like